Nashville, TN (September 12, 2018) – Three leading oncology practices unite with partners in technology and finance to announce the launch of OneOncology, a patient-centric, physician-driven, and technology-powered company with a mission to improve the lives of everyone living with cancer.
An estimated 38 percent of Americans will be diagnosed with cancer in their lifetimes. Fortunately, with breakthroughs in diagnostic testing, targeted and immunotherapies, and surgical procedures, cancer is being detected earlier and survivorship is increasing. More than half of those diagnosed with cancer in the U.S. are being treated in a community-based setting, providing high-quality care closer to patients’ homes, at costs up to 60 percent less than in acute care hospitals.
Despite their critical role, community oncology practices face enormous challenges, including increased pressure from hospital consolidation, limited resources to invest in innovation, and continued shifts to alternative payment models.
Ad Statistics
Times Displayed: 45539
Times Visited: 1362 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
OneOncology empowers community oncology practices by supporting the entire continuum of care, including prevention and diagnosis, research and treatment, long-term survivorship, and palliative and hospice care. Through this comprehensive approach, OneOncology aims to achieve improved patient experience and outcomes while benefiting their providers and payers through better aligned payment models.
“With the launch of OneOncology, we hope to transform the future of cancer care,” said Tracy Bahl, OneOncology’s President & Chief Executive Officer. The 20-year healthcare industry veteran sees a need in the marketplace for a better cancer care model. “Cancer is increasingly being treated like a chronic condition rather than a terminal diagnosis. Working together with world-class oncologists, we will drive the change that community cancer needs through continual learning, creative and smart evolution, and a collective desire to positively impact the lives of every person touched by cancer.”
OneOncology’s founding practices are recognized as three of the nation’s leading community-based cancer care centers. Dr. Jeff Patton, CEO of Tennessee Oncology, Dr. Jeff Vacirca, CEO of New York Cancer & Blood Specialists, and Dr. Lee Schwartzberg, Executive Director of West Cancer Center, all believe that this partnership will enable the nation’s best oncologists to learn from unique challenges, drive meaningful innovation, and leverage the benefits for patients.
